THINKMD has released a screening and educational tool that guides users through a COVID-19 self-risk assessment, as well as providing users with WHO and CDC educational information on how and when to seek medical care, and recommended protective and preventive measures.

Each personal assessment determines if an individual has none, some or many of the clinical symptoms and presenting features associated with COVID-19. The tool is based on the latest published peer-reviewed WHO and CDC clinical data on presenting signs, symptoms and risk factors.

The progressive web-based application is functional on any desktop, tablet or smartphone. It will also be available via SMS/USSD for feature phone users to ensure widespread global distribution. The tool will also be available to use offline by health organizations in areas with limited connectivity. THINKMD is offering the tool completely free of charge.

Based in Burlington, Vermont, Goodwin client THINKMD develops next generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology decentralizes healthcare delivery into communities and homes by pairing clinical knowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology.

The goal of the COVID-19 tool is provide personal triage and pandemic information to lessen the burden on healthcare systems and increase healthcare capacity and quality where it is most limited. The tool captures time-specific health and epidemiology data that can help health agencies develop and monitor response strategies to mitigate the spread of COVID-19 and to maximize care for those who need it the most.

THINKMD’s COVID-19 screening tool is also dynamic and will be updated and expanded as new clinical and public health data is acquired and as country-specific health agencies update their responses, guidelines and recommendations as the pandemic progresses.

The tool is available in an expanding list of languages – currently, it is available in English, French, Spanish, Arabic, Portuguese, Hindi, and Bengali. The company is working to distribute this tool as rapidly and as widely as possible. Since its recent online release, it has been accessed and used in over 50 countries.

For those interested in using this tool, access it by pasting this URL into your browser: https://covid19.thinkmd.tech/go

For those interested in distributing this tool, please email [email protected].

THINKMD at a Glance

  • Private company
  • Founded in 2015
  • Headquartered in Burlington, Vt.
  • 12 employees
  • Goodwin client since 2015